Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	93.28	-194.34	-2890.18
Graham Fair Price	4.72	1.25	1.19
PEG	-15.33	-0.55	-0.48
Price/Book	4.70	27.23	26.01
Price/Cash Flow	-95.32	-112.97	2412.33
Prices/Earnings	40.29	-18.38	-30.78
Price/Sales	-10.95	32.24	36.20
Price/FCF	-95.32	-112.97	2412.33
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.84	0.86	0.88
Operating Margin	-511.99	-0.20	-0.03
ROA	-54.19	-0.07	-0.04
ROE	-0.21	-0.37	-75.34
ROIC	< 0.005	-0.05	-543.74
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.02	93.73
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.78	-4.87	522.01
EPS QOQ	-0.64	-0.33	48.23
FCF QOQ	1.04	-19.24	1744.51
Revenue QOQ	0.11	-0.04	-63.66
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	397.80	347.83	-12.56
Days Sales Outstanding (DSO)	68.53	62.31	-9.08
Inventory Turnover	0.23	0.26	14.36
Debt/Capitalization	0.71	0.75	5.63
Quick Ratio	2.23	2.22	-0.24
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.55	0.43	-20.91
Cash	0.97	0.79	-18.85
Capex	< 0.005	< 0.005	-1.41
Free Cash Flow	< 0.005	-0.10	1668.25
Revenue	0.39	0.36	-7.01
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.88	3.03	5.35
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-131.17	-12.02	90.83
Naive Interpretation	Member

06 - Financial Health · Bad

Rating